"I Choose to be Safe!"

Empowering Early Detection and Intervention of Opioid-Induced Overdose

1235-Nov-2023 PNW Design Flyer V2_BLEED (1)-min

Welcome to PneumoWave, where we are revolutionizing how we address the critical issue of opioid-induced respiratory depression (OIRD). By harnessing the potential of advanced data analytics, we empower timely interventions that can save lives and prevent respiratory distress.

1235-Nov-2023 PNW Design Flyer V2_BLEED (1)-min

"I Choose to be Safe!"

Empowering Early Detection and Intervention of Opioid-Induced Overdose

Welcome to PneumoWave, where we are revolutionizing how we address the critical issue of opioid-induced respiratory depression (OIRD). By harnessing the potential of advanced data analytics, we empower timely interventions that can save lives and prevent respiratory distress.

Real-Time Respiratory Depression Monitoring

PneumoWave is an integrated platform of patient data capture and proprietary analysis.

Our solutions aim to facilitate a paradigm shift in respiratory care focusing on intervention before disease or injury has advanced.

24/7 Repiratory Monitoring

Our small, chest-worn biosensor continuously captures data and transmits it wirelessly for analysis.

Real-time Results

Proprietary algorithms aim to accurately detect a range of respiratory adverse events in real-time.

Cloud Platform

Processed data can be viewed in our cloud platform, allowing clinicians to remotely provide personalized treatment.

Alert System

Our alert system promptly notifies healthcare providers of potential respiratory distress, enabling timely interventions.

24/7 Repiratory Monitoring

Our small, chest-worn biosensor continuously captures data and transmits it wirelessly for analysis.

Cloud Platform

Processed data can be viewed in our cloud platform, allowing clinicians to remotely provide personalized treatment.

Real-Time Respiratory Depression Monitoring

pnumawavex600-min

PneumoWave is an integrated platform of patient data capture and proprietary analysis.

Our solutions aim to facilitate a paradigm shift in respiratory care focusing on intervention before disease or injury has advanced.

Real-time Results

Proprietary algorithms aim to accurately detect a range of respiratory adverse events in real-time.

Alert System

Our alert system promptly notifies healthcare providers of potential respiratory distress, enabling timely interventions.

How It Works

Step 1

The Opioid Epidemic Poses An Urgent Unmet Medical Need

Towards the end of the 20th century, misleading information by several pharmaceutical companies, claiming their opioid painkillers were non-addictive, triggered a surge in prescriptions across the United States for individuals with chronic pain.

At the same time, the increased availability of opioids created a concerning trend, as individuals with emotional trauma and mental health conditions sought solace in these drugs, chasing the temporary euphoria they provided and unknowingly falling into rapid dependency.

Today, the misuse of prescription and illicit opioids is the leading cause of death in most developed nations. Within the United States alone, it has evolved into a public health emergency, claiming the lives of over 70,000 individuals last year (CDC).

From 1999-2019

Involving both prescription & illicit opioids

Our Team

Dr. Bruce Henderson

Dr. Bruce Henderson

CEO

richie-bavasso

Richie Bavasso

President

Stuart kelly

Stuart Kelly

CTO

Dr-Osian-Meredith

Dr. Osian Meredith

CSO

News

Contact us directly for any media enquiries:
enquiries@pneumowave.com

£5.2 m equity from Scottish National Investment Bank alongside £2.3 m from existing investors Scottish Enterprise, IIG, London & Scottish…

Press Release
January 12, 2023

Digital therapeutics company PneumoWave (formerly known as Altair Medical) announced today the use of their monitoring platform in a clinical trial led by Professor Sir John Strang at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.

Press Release
January 19, 2022

Tuesday 2nd November Digital therapeutics company PneumoWave (formerly known as Altair Medical) announced today the commencement of a second clinical…

Press Release
November 2, 2021

Clinical Trial Partners

Contact Us

Please contact us with any enquiries. We will aim to respond to your query as soon as possible.

UK Location

PneumoWave, LTD

Suites 3 and 4

Second Floor, Maxim 3

Maxim Office Park

Parklands Avenue

Eurocentral ML1 4WQ

UK

USA Location(s)

PneumoWave, Inc.

4900 O’Hear Avenue, Suite 100

North Charleston, SC  29405

USA

 

421 Fayetteville Street,

Suite 1100,

Raleigh, NC 27601

USA

 

Please enable JavaScript in your browser to complete this form.
Name

"I Choose to be Safe!"

Empowering Early Detection and Intervention of Opioid-Induced Overdose

1235-Nov-2023 PNW Design Flyer V2_BLEED (1)-min

Welcome to PneumoWave, where we are revolutionizing how we address the critical issue of opioid-induced respiratory depression (OIRD). By harnessing the potential of advanced data analytics, we empower timely interventions that can save lives and prevent respiratory distress.

1235-Nov-2023 PNW Design Flyer V2_BLEED (1)-min

"I Choose to be Safe!"

Empowering Early Detection and Intervention of Opioid-Induced Overdose

Welcome to PneumoWave, where we are revolutionizing how we address the critical issue of opioid-induced respiratory depression (OIRD). By harnessing the potential of advanced data analytics, we empower timely interventions that can save lives and prevent respiratory distress.

Real-Time Respiratory Depression Monitoring

PneumoWave is an integrated platform of patient data capture and proprietary analysis.

Our solutions aim to facilitate a paradigm shift in respiratory care focusing on intervention before disease or injury has advanced.

24/7 Repiratory Monitoring

Our small, chest-worn biosensor continuously captures data and transmits it wirelessly for analysis.

Real-time Results

Proprietary algorithms aim to accurately detect a range of respiratory adverse events in real-time.

Cloud Platform

Processed data can be viewed in our cloud platform, allowing clinicians to remotely provide personalized treatment.

Alert System

Our alert system promptly notifies healthcare providers of potential respiratory distress, enabling timely interventions.

24/7 Repiratory Monitoring

Our small, chest-worn biosensor continuously captures data and transmits it wirelessly for analysis.

Cloud Platform

Processed data can be viewed in our cloud platform, allowing clinicians to remotely provide personalized treatment.

Real-Time Respiratory Depression Monitoring

pnumawavex600-min

PneumoWave is an integrated platform of patient data capture and proprietary analysis.

Our solutions aim to facilitate a paradigm shift in respiratory care focusing on intervention before disease or injury has advanced.

Real-time Results

Proprietary algorithms aim to accurately detect a range of respiratory adverse events in real-time.

Alert System

Our alert system promptly notifies healthcare providers of potential respiratory distress, enabling timely interventions.

How It Works

Step 1

The Opioid Epidemic Poses An Urgent Unmet Medical Need

Towards the end of the 20th century, misleading information by several pharmaceutical companies, claiming their opioid painkillers were non-addictive, triggered a surge in prescriptions across the United States for individuals with chronic pain.

At the same time, the increased availability of opioids created a concerning trend, as individuals with emotional trauma and mental health conditions sought solace in these drugs, chasing the temporary euphoria they provided and unknowingly falling into rapid dependency.

Today, the misuse of prescription and illicit opioids is the leading cause of death in most developed nations. Within the United States alone, it has evolved into a public health emergency, claiming the lives of over 70,000 individuals last year (CDC).

From 1999-2019

Involving both prescription & illicit opioids

Our Team

Dr. Bruce Henderson

Dr. Bruce Henderson

CEO

richie-bavasso

Richie Bavasso

President

Stuart kelly

Stuart Kelly

CTO

Dr-Osian-Meredith

Dr. Osian Meredith

CSO

News

Contact us directly for any media enquiries:
enquiries@pneumowave.com

£5.2 m equity from Scottish National Investment Bank alongside £2.3 m from existing investors Scottish Enterprise, IIG, London & Scottish…

Press Release
January 12, 2023

Digital therapeutics company PneumoWave (formerly known as Altair Medical) announced today the use of their monitoring platform in a clinical trial led by Professor Sir John Strang at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.

Press Release
January 19, 2022

Tuesday 2nd November Digital therapeutics company PneumoWave (formerly known as Altair Medical) announced today the commencement of a second clinical…

Press Release
November 2, 2021

Clinical Trial Partners

Careers

View our list of open positions below. Please do not hesitate to contact us with any questions about your application.

Software Development Manager
(Medical Devices)

Full-time, Permanent, Eurocentral

Contact Us

Please contact us with any enquiries. We will aim to respond to your query as soon as possible.

UK Location

PneumoWave, LTD

Suites 3 and 4

Second Floor, Maxim 3

Maxim Office Park

Parklands Avenue

Eurocentral ML1 4WQ

UK

USA Location(s)

PneumoWave, Inc.

4900 O’Hear Avenue, Suite 100, 

PMB# 511

North Charleston, SC  29405

USA

PneumoWave, Inc.
421 Fayetteville Street, Suite 1100,
Raleigh, NC 27601
USA

Please enable JavaScript in your browser to complete this form.
Name